secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023417
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q1 revenue $34.7M (+9% YoY); Adj. EBITDA $6.3M (+64%)
----------------------------------------------------------------

- Net revenue $34.7M (+9% YoY); net loss narrowed to $0.3M ($0.01 loss per share) from $1.1M.
- Adjusted EBITDA $6.3M (+64% YoY); margin expanded 6.2pp to 18.2%.
- Patient Services revenue up 12% to $20.8M; Device Solutions up 4% to $13.9M.
- FY 2025 guidance reaffirmed: revenue growth 8-10%; Adj. EBITDA margin high teens.
- CEO transition: Richard DiIorio out; Carrie Lachance (COO) incoming; $1.0M severance accrued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025023417/0001628280-25-023417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025023417/infu-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer